ArticleEuropean heart journal. Case reports2026
Dual HeartMate 3 in total artificial heart configuration for incessant ventricular fibrillation: a case report.
Article in European heart journal. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Ventricular arrhythmias are a major therapeutic challenge in the management of advanced heart failure, which often complicates the use of conventional mechanical circulatory support (MCS). Case summary: A 46-year-old man with advanced heart failure developed refractory ventricular tachyarrhythmias. He experienced progressive haemodynamic instability, which necessitated a stepwise escalation of temporary MCS. Despite adequate ventricular unloading and acute antiarrhythmic management, his rhythm deteriorated into incessant ventricular fibrillation that lasted for 28 days. Given the low possibility of myocardial recovery and an anticipated waiting time of more than 2 months (even with urgent listing for heart transplantation in our country), the temporary MCS was transitioned to durable biventricular support using two HeartMate 3 devices in a total artificial heart configuration. This configuration eliminated arrhythmogenic and thrombogenic myocardial substrates and provided stable circulatory support. The patient resumed early active rehabilitation and received a heart transplant after 72 days of dual HeartMate 3 support without adverse events such as pump thrombosis, haemolysis, stroke, or bleeding during support. Discussion: This case demonstrates that using two continuous-flow ventricular assist devices in a total artificial heart configuration may represent a viable strategy of advanced mechanical circulatory support in highly selected patients with refractory ventricular arrhythmia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.